They also opened the way to anticancer treatments using zinc, in combination with classical chemotherapy, to restore WTp53 activity when cancers present low expression of HIPK2 [57] or in p53-functionally deficient cancer cells [60]. The gene discussed is HIPK2; the disease is cancer.